Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Live vaccine use and safety in digeorge syndrome
Annika M. Hofstetter
, Kathleen Jakob
, Nicola P. Klein
, Cornelia L. Dekker
, Kathryn M. Edwards
, Neal A. Halsey
, Roger Baxter
, S. Elizabeth Williams
, Philip L. Graham
, Philip LaRussa
Research output
:
Contribution to journal
›
Article
›
peer-review
22
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Live vaccine use and safety in digeorge syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Vaccine Safety
100%
Vaccine Use
100%
Live Vaccine
100%
DiGeorge Syndrome
100%
Adverse Events
50%
Varicella Vaccine
50%
Measles-mumps-rubella Vaccine
50%
Live Vaccination
50%
Vaccine-preventable Diseases
33%
Vaccination Coverage
33%
Diagnostic Confirmation
33%
Vaccination Patterns
33%
Vaccination Timeliness
33%
Between-subject
16%
Fluorescence in Situ Hybridization
16%
Multivariable
16%
Multicenter Retrospective Study
16%
Immunization
16%
Vaccine Dose
16%
Congenital Disorders
16%
Immunosuppression
16%
Immune Function
16%
Cellular Immune Response
16%
Early Diagnostics
16%
Medical History
16%
Bivariate
16%
22q11.2 Microdeletion
16%
Unvaccinated
16%
Chromosome 22q11.2
16%
Immune Deficiency
16%
Baseline CD4
16%
Recommended Vaccinations
16%
Vaccine Recipients
16%
Vaccine Utilization
16%
Medicine and Dentistry
Chickenpox Vaccine
100%
DiGeorge Syndrome
100%
Live Vaccine
100%
Adverse Event
100%
Vaccination Coverage
66%
Measles Mumps Rubella Vaccine
66%
Diseases
66%
Retrospective Cohort Study
33%
Fluorescence in Situ Hybridization
33%
Immune Deficiency
33%
Immunosuppressive Treatment
33%
Congenital Disorder
33%
Immune Function
33%
Measles
33%
Mumps
33%
Rubella
33%
Medical History
33%
Chromosome
33%
Immunology and Microbiology
CD4
100%
Live Vaccine
100%
Attenuated Vaccine
100%
DiGeorge Syndrome
100%
Varicella Vaccine
100%
MMR Vaccine
66%
Fluorescence in Situ Hybridization
33%
Immunosuppression
33%
Measles
33%
Immunodeficiency
33%
Rubella
33%
Chromosome
33%
Pharmacology, Toxicology and Pharmaceutical Science
Live Vaccine
100%
DiGeorge Syndrome
100%
Vaccination
100%
Adverse Event
37%
Chickenpox Vaccine
37%
Measles Mumps Rubella Vaccine
25%
Diseases
25%
Cohort Study
12%
Medical History
12%
Immune Deficiency
12%
Mumps
12%
Measles
12%
Congenital Disorder
12%
Rubella
12%